• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于将通路拓扑知识纳入关联研究的贝叶斯基因组模型。

Bayseian genomic models for the incorporation of pathway topology knowledge into association studies.

作者信息

Brisbin Abra, Fridley Brooke L

机构信息

Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

出版信息

Stat Appl Genet Mol Biol. 2013 Aug;12(4):505-16. doi: 10.1515/sagmb-2012-0061.

DOI:10.1515/sagmb-2012-0061
PMID:23934611
Abstract

Pathway topology and relationships between genes have the potential to provide information for modeling effects of mRNA gene expression on complex traits. For example, researchers may wish to incorporate the prior belief that "hub" genes (genes with many neighbors) are more likely to influence the trait. In this paper, we propose and compare six Bayesian pathway-based prior models to incorporate pathway topology information into association analyses. Including prior information regarding the relationships among genes in a pathway was effective in somewhat improving detection rates for genes associated with complex traits. Through an extensive set of simulations, we found that when hub (central) effects are expected, the diagonal degree model is preferred; when spoke (edge) effects are expected, the spatial power model is preferred. When there is no prior knowledge about the location of the effect genes in the pathway (e.g., hub versus spoke model), it is worthwhile to apply multiple models, as the model with the best DIC is not always the one with the best detection rate. We also applied the models to pharmacogenomic studies for the drugs gemcitabine and 6-mercaptopurine and found that the diagonal degree model identified an association between 6-mercaptopurine response and expression of the gene SLC28A3, which was not detectable using the model including no pathway information. These results demonstrate the value of incorporating pathway information into association analyses.

摘要

通路拓扑结构以及基因之间的关系有潜力为模拟mRNA基因表达对复杂性状的影响提供信息。例如,研究人员可能希望纳入“枢纽”基因(有许多邻居的基因)更有可能影响性状这一先验信念。在本文中,我们提出并比较了六种基于贝叶斯通路的先验模型,以将通路拓扑信息纳入关联分析。纳入关于通路中基因间关系的先验信息在一定程度上有效地提高了与复杂性状相关基因的检测率。通过大量模拟,我们发现,当预期有枢纽(中心)效应时,对角度模型更优;当预期有辐条(边缘)效应时,空间幂模型更优。当对通路中效应基因的位置没有先验知识时(例如,枢纽与辐条模型),应用多个模型是值得的,因为具有最佳DIC的模型并不总是具有最佳检测率的模型。我们还将这些模型应用于吉西他滨和6-巯基嘌呤药物的药物基因组学研究,发现对角度模型确定了6-巯基嘌呤反应与基因SLC28A3表达之间的关联,而使用不包含通路信息的模型则无法检测到这种关联。这些结果证明了将通路信息纳入关联分析的价值。

相似文献

1
Bayseian genomic models for the incorporation of pathway topology knowledge into association studies.用于将通路拓扑知识纳入关联研究的贝叶斯基因组模型。
Stat Appl Genet Mol Biol. 2013 Aug;12(4):505-16. doi: 10.1515/sagmb-2012-0061.
2
A Bayesian integrative genomic model for pathway analysis of complex traits.贝叶斯整合基因组模型用于复杂性状的通路分析。
Genet Epidemiol. 2012 May;36(4):352-9. doi: 10.1002/gepi.21628. Epub 2012 Mar 28.
3
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.原发性卵巢癌中核苷转运体、脱氧胞苷激酶、核糖核苷酸还原酶调节亚基和吉西他滨代谢酶的表达。
Cancer Chemother Pharmacol. 2010 Mar;65(4):679-86. doi: 10.1007/s00280-009-1073-y. Epub 2009 Jul 29.
4
Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis.利用加权稀疏典型相关分析对药物基因组学研究中的多种数据类型进行同步分析。
OMICS. 2012 Jul-Aug;16(7-8):363-73. doi: 10.1089/omi.2011.0126. Epub 2012 Jun 26.
5
Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.胞质5'-核苷酸酶III(NT5C3):基因序列变异与功能基因组学
Pharmacogenet Genomics. 2009 Aug;19(8):567-76. doi: 10.1097/FPC.0b013e32832c14b8.
6
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours.SLC28A3 基因型和吉西他滨输注率影响实体瘤患者的 dFdCTP 代谢产物处置。
Br J Cancer. 2014 Jan 21;110(2):304-12. doi: 10.1038/bjc.2013.738. Epub 2013 Dec 3.
7
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.基于通路的实体瘤患者吉西他滨药代动力学的药物基因组学研究。
Pharmacogenomics. 2012 Jul;13(9):1009-21. doi: 10.2217/pgs.12.81.
8
Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.吉西他滨在人淋巴细胞中的细胞毒性活性及其与药物相关基因表达谱的相关性。
Pharmacol Res. 2007 Apr;55(4):343-9. doi: 10.1016/j.phrs.2007.01.003. Epub 2007 Jan 16.
9
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.曲古抑菌素A与吉西他滨协同抑制胰腺腺癌细胞生长
Biochim Biophys Acta. 2007 Jul;1773(7):1095-106. doi: 10.1016/j.bbamcr.2007.05.002. Epub 2007 May 22.
10
Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5'-nucleotidase activity.在具有升高的5'-核苷酸酶活性的克拉屈滨耐药HL60细胞中,与吉西他滨和阿糖胞苷不存在交叉耐药性。
Exp Hematol. 1998 Dec;26(13):1223-8.